• Vetiranary Medicine
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Top Recommended Veterinary Products
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Cancer experts from Colorado universities partner to bring carbon-ion radiotherapy to U.S.

October 1, 2014

Feasibility study is first step toward $300 mil. facility for cutting edge cancer treatment for humans and companion animals.

>>> Researchers hope the feasibility study brings carbon-ion radiotherapy as seen above to the United States. (Photo courtesy of University of Colorado.)Cancer experts from Colorado University and Colorado State (CSU), including researchers from the CSU Flint Animal Cancer Center, announced a $200,000 feasibility study to support building the nation's first carbon-ion radiotherapy research and treatment facility in Aurora, Colo. Carbon-ion therapy is proven effective against the deadliest cancers, but is currently only available in Europe and Japan.

According to releases from both universities, collaborators will meet Oct. 2 at the University of Colorado Anschutz Medical Campus in Aurora to discuss plans for the estimated $300 million research and treatment facility. The project is connected with University of Colorado Health's Poudre Valley Hospital in Fort Collins, Colo., and with carbon-ion radiotherapy pioneers at the National Institute of Radiological Sciences in Japan. “It's clear that our collaboration offers distinct advantages for an international carbon-ion center that would provide truly needed help for animal and human cancer patients,” says Mark Stetter, dean of the CSU College of Veterinary Medicine and Biomedical Sciences, in a release.

The Flint Animal Cancer Center specializing in treating cats and dogs with naturally occurring cancer provides critical translational medicine that CSU says is the cornerstone of the carbon-ion therapy proposal. Research and treatment at the proposed facility would accelerate companion animal oncology work benefitting pets and people.

Advertisement

Jac Nickoloff, a radiation researcher and head of the CSU Department of Environmental and Radiological Health Sciences, explained that carbon ions, compared to the protons and photons traditionally used in radiotherapy, are more precisely targeted to tumors and have been shown to cause minimal damage to normal tissues en route to tumors. Carbon-ion radiotherapy is also notable for creating more lethal damage to DNA in tumor cells-making it effective in killing tumors that are resistant to traditional therapies. Studies show that carbon-ion radiation is safe, well tolerated by patients and works on many types of cancer with few side effects, Nickoloff said.

The University of Colorado, Colorado State University and key university units involved in the project contributed funding for the feasibility study.

Related Content:

OncologyMedicalBreaking News
3 categories of inappetence in dogs
3 categories of inappetence in dogs
UC Davis oral surgeons repair kitten’s severe cleft palate
UC Davis oral surgeons repair kitten’s severe cleft palate
Tips and tricks for diagnosing canine osteoarthritis early
Tips and tricks for diagnosing canine osteoarthritis early

Advertisement

Latest News

Managing wounds in pet patients

Spectrum of care: protocols to support pet owners’ budgets

How to support women while still running a successful business

The Vets expands to Raleigh, NC

View More Latest News
Advertisement